JPRN-jRCT2080223839已完成1 期
A Multicenter, Open-Label, Non-Comparative Study in Patients with Resectable Malignancies (Gastric Cancer/Non-Small Cell Lung Cancer)(ONO-4538-67)
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 60 人开始时间: 2018年3月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- •2. Eligible for surgical resection with curative intent
- •3. Pathologically confirmed diagnosis of primary NSCLC or Gastric adenocarcinoma
排除标准
- •1. Advanced or metastatic malignancies
- •2. Multiple cancer
- •3. Complication or history of severe hypersensitivity reactions to antibodies and any other drugs
研究者
相似试验
进行中（未招募）
不适用
A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, InclusiveCrohn's DiseaseEUCTR2011-003743-22-DEAstraZeneca AB110
进行中（未招募）
1 期
A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, InclusiveMedDRA version: 14.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2011-003743-22-ITASTRAZENECA123
进行中（未招募）
不适用
A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort™ EC as a Maintenance Treatment for Crohn’s Disease in Paediatric Subjects Aged 5 to 17 Years, InclusiveMedDRA version: 14.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2011-003742-40-DEAstraZeneca AB50
进行中（未招募）
不适用
Study of CANCIDAS in Children types of ungal infectionsCandida and Aspergillus infectionsEUCTR2014-004911-35-Outside-EU/EEAMerck & Co., Inc.50
未知
不适用
A Study for Patients With Non-Hodgkin´s Lymphomas-C859 Non-Hodgkin lymphoma, unspecifiedNon-Hodgkin lymphoma, unspecifiedC859PER-006-08ELI LILLY AND COMPANY,